MGC12916: Potential Drug Target Or Biomarker (G84815)

Target Name: MGC12916

NCBI ID: G84815

Other Name(s): uncharacterized protein MGC12916 | Uncharacterized protein MGC12916

MGC12916: Potential Drug Target Or Biomarker

MGC12916 is a protein that has not yet been characterized, but it is potential drug target or biomarker. It is a glycoprotein that is expressed in various tissues and organs, including the brain, heart, liver, and muscle. MGC12916 is a protein that is known to play a role in the regulation of cell growth, apoptosis, and angiogenesis.

One of the key functions of MGC12916 is its role in cell apoptosis. Apoptosis is a natural process that helps the body eliminate damaged or dysfunctional cells. During apoptosis, MGC12916 is involved in the formation of a protein complex called Bcl-2-associated death domain-containing (BADC) complex. This complex is known to play a role in preventing apoptosis and has been implicated in a number of diseases, including cancer.

Another function of MGC12916 is its role in cell growth. MGC12916 has been shown to play a role in the regulation of cell proliferation and has been shown to promote the growth of various types of cancer cells. This may make MGC12916 a potential drug target for cancer treatment.

MGC12916 has also been shown to be involved in the regulation of angiogenesis. Angiogenesis is the process by which new blood vessels form in the body. MGC12916 has been shown to play a role in the regulation of angiogenesis and has been shown to be involved in the development of various diseases, including cancer.

In conclusion, MGC12916 is a protein that is involved in a number of important functions in the body, including cell apoptosis, growth, and angiogenesis. As such, it is a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of MGC12916 in the body and to develop effective treatments for those diseases.

Protein Name: Uncharacterized Protein MGC12916

More Common Targets